NCT07504848

Brief Summary

This study was designed to determine the effect of functional mobility levels of stroke patients on caregiver burden, anxiety, and depression in their caregivers.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
64

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Apr 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 26, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 1, 2026

Completed
1 day until next milestone

Study Start

First participant enrolled

April 2, 2026

Completed
13 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 15, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 15, 2026

Completed
Last Updated

April 1, 2026

Status Verified

March 1, 2026

Enrollment Period

13 days

First QC Date

March 26, 2026

Last Update Submit

March 26, 2026

Conditions

Outcome Measures

Primary Outcomes (6)

  • Brunnstrom Stages of Hemiplegic Recovery

    Baseline

  • Beck Depression Inventory

    Baseline

  • Beck Anxiety Inventory

    Baseline

  • Burden Interview

    Baseline

  • Timed Up and Go Test

    Baseline

  • Rivermead Mobility Index

    Baseline

Study Arms (2)

Stroke Patients

Caregivers

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This study includes adult individuals with a first-ever unilateral stroke and their primary caregivers. Stroke patients aged 18-75 years, at least 3 months post-stroke, with sufficient cognitive function (MMSE ≥24), and stable medical status are included. Caregivers are adults who have been living with the patient for at least one year and are the primary, non-professional caregivers.

You may qualify if:

  • Stroke Patients:
  • Diagnosed with stroke according to WHO criteria (≥20% disability rate documented in Adult Disability Health Board Report)
  • Having a family member or relative who provides care
  • First-ever and unilateral stroke
  • Willing to participate voluntarily
  • Aged between 18-75 years
  • Post-stroke duration longer than 3 months
  • Stable vital signs
  • Scoring ≥24 on the Standardized Mini-Mental State Examination (SMMT) or the -Modified Mini-Mental State Examination for Illiterate Individuals (MMSE-E)
  • Able to understand and speak Turkish
  • Caregivers of Stroke Patients:
  • Willing to participate in the study
  • Living with the patient for at least 1 year
  • Being the primary (main responsible) caregiver and not receiving paid professional caregiving services
  • Aged 18 years or older
  • +1 more criteria

You may not qualify if:

  • Stroke Patients:
  • Presence of severe comorbid conditions
  • Unwillingness to participate
  • History of multiple strokes
  • Bilateral hemiplegia
  • Presence of major neurological, orthopedic, or rheumatologic disorders affecting the musculoskeletal system other than stroke
  • Congenital anomalies or amputation causing disability
  • Uncontrolled arrhythmia, uncontrolled hypertension, or unstable cardiac conditions
  • Botulinum toxin injection within the last 6 months
  • Inability to establish cooperation
  • Presence of neglect, aphasia, or hemianopsia
  • Caregivers of Stroke Patients:
  • Unwillingness to participate
  • Living with the patient for less than 1 year
  • Presence of mental retardation, dementia, or severe psychotic disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Central Study Contacts

Seda Nur Kemer, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer, PhD

Study Record Dates

First Submitted

March 26, 2026

First Posted

April 1, 2026

Study Start

April 2, 2026

Primary Completion

April 15, 2026

Study Completion

April 15, 2026

Last Updated

April 1, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share